[1] JIANG X J,WEST A A,CAUDILL M A.Maternal choline supplementation:a nutritional approach for improving offspring health[J].Trends in Endocrinology and Metabolism:TEM,2014,25(5):263-273.

[2] CORBIN K D,ZEISEL S H.Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression[J].Current Opinion in Gastroenterology,2012,28(2):159-165.

[3] ZEISEL S H.Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis[J].Clinical Chemistry and Abrator Medicine,2013,51(3):467-475.
[4] SHEN J,SUN B F,YU C,et al.Choline and methionine regulate lipid metabolism via the AMPK signaling pathway in hepatocytes exposed to high concentrations of nonesterified fatty acids[J].Journal of Cellular Biochemistry,2019,121(8/9):3667-3678.
[5] GOSELINK R M A,VAN BAAL J,WIDJAJA H C A,et al.Effect of rumen-protected choline supplementation on liver and adipose gene expression during the transition period in dairy cattle[J].Journal of Dairy Science,2013,96(2):1102-1116.

[6] CASTRO N,KAWASHIMA C,VAN DORLAND H A,et al.Metabolic and energy status during the dry period is crucial for the resumption of ovarian activity postpartum in dairy cows[J].Journal of Dairy Science,2012,95(10):5804-5812.

[7] HAMMON H M,STÜRMER G,SCHNEIDER F,et al.Performance and metabolic and endocrine changes with emphasis on glucose metabolism in high-yielding dairy cows with high and low fat content in liver after calving[J].Journal of Dairy Science,2009,92(4):1554-1566.

[8] CHANDLER T L,WHITE H M.Glucose metabolism is differentially altered by choline and methionine in bovine neonatal hepatocytes[J].PLoS One,2019,14(5):e0217160.
[9] LIN B C,MORRIS D W,CHOU J Y.The role of HNF1α,HNF3γ,and Cyclic AMP in glucose-6-phosphatase gene activation[J].Biochem,1997,36(46):14096-14106.

[10] VAN SCHAFTINGEN E,GERIN I.The glucose-6-phosphatase system[J].Biochemical Journal,2002,362:513-532.
[11] SOTY M,CHILLOUX J,DELALANDE F,et al.Post-translational regulation of the glucose-6-phosphatase complex by cyclic adenosine monophosphate is a crucial determinant of endogenous glucose production and is controlled by the glucose-6-phosphate transporter[J].Journal of Proteome Research,2016,15(4):1342-1349.

[12] WANG B,HSU S H,FRANKEL W,et al.Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma,Coactivator 1 Alpha[J].Hepatology,2012,56(1):186-197.

[13] BARTEL D P.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.

[14] INOUE H,OGAWA W,OZAKI M,et al.Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism
in vivo[J].Nature Medicine,2004,10(2):168-174.

[15] ZHANG M,ZHAO Y J,LI Z,et al.Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis[J].Biochemical and Biophysical Research Communications,2018,495(1):582-586.

[16] ZHU L X,BAKER S S,SHAHEIN A,et al.Upregulation of non-canonical Wnt ligands and oxidative glucose metabolism in NASH induced by methionine-choline deficient diet[J].Trends in Cell & Molecular Biology,2018,13:47-56.
[17] TOULIS K A,NIRANTHARAKUMAR K,POURZITAKI C,et al.Glucokinase activators for type 2 diabetes:challenges and future developments[J].Drugs,2020,80(5):467-475.

[18] POOYA S,BLAISE S,MORENO G M,et al.Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α,ERR-α,and HNF-4α in the rat liver[J].Journal of Hepatology,2012,57(2):344-351.

[19] JHA P,KNOPF A,KOEFELER H,et al.Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH)[J].Biochimica et Biophysica Acta:Molecular Basis of Disease,2014,1842(7):959-970.

[20] 孙菲菲.胆碱和蛋氨酸对奶牛围产期营养平衡和机体健康的影响及机制[D].博士学位论文.杨凌:西北农林科技大学,2017. SUN F F.Choline and methionine regulate nutrient balance and health of transition dairy cows:Responses and potential mechnisms[D].Ph.D.Thesis.Yangling:Northwest A&F University,2017.(in Chinese)
[21] 严琳玲.葡萄糖-6-磷酸脱氢酶在糖尿病及其并发症中的作用及机制[J].医学综述,2015,21(5):848-851. YAN L L.The role and mechanism of glucose-6-phosphate dehydrogenase in diabetes and its complications[J].Medical Recapitulate,2015,21(5):848-851.(in Chinese)
[22] VLASSARA H.Advanced glycation in health and disease:role of the modern environment[J].Annals of the New York Academy of Sciences,2005,1043(1):452-460.

[23] STRIKER G E,VLASSARA H.AGE restriction in diabetes mellitus:a paradigm shift[J].Nature Reviews.Endocrinology,2011,7(9):526-539.

[24] STITT A W,JENKINS A J,COOPER M E.Advanced glycation end products and diabetic complications[J].Expert Opinion on Investigational Drugs,2002,11(9):1205-1223.

[25] ZONG H L,WARD M,STITT A W.AGEs,RAGE,and diabetic retinopathy[J].Current Diabetes Reports,2011,11(4):244-252.

[26] FEIGE J N,AUWERX J.Transcriptional targets of sirtuins in the coordination of mammalian physiology[J].Current Opinion in Cell Biology,2008,20(3):303-309.

[27] SCHWER B,VERDIN E.Conserved metabolic regulatory functions of sirtuins[J].Cell Metabolism,2008,7(2):104-112.

[28] YU J J,AUWERX J.Protein deacetylation by SIRT1:an emerging key post-translational modification in metabolic regulation[J].Pharmacological Research,2010,62(1):35-41.

[29] HERRANZ D,SERRANO M.SIRT1:recent lessons from mouse models[J].Nature Reviews Cancer,2010,10(12):819-823.

[30] JIANG J X,CHEN X L,FUKADA H,et al.Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice[J].Hepatology,2013,58(4):1339-1348.

[31] CARDELLINI M,MENGHINI R,MARTELLI E,et al.TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1[J].Diabetes,2009,58(10):2396-2401.

[32] JIANG J X,VENUGOPAL S,SERIZAWA N,et al.Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis
in vivo[J].Gastroenterology,2010,139(4):1375-1384.e4.

[33] PAIK Y H,IWAISAKO K,SEKI E,et al.The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91
phox mediate hepatic fibrosis in mice[J].Hepatology,2011,53(3):1730-1741.
[34] KAHN B B,ALQUIER T,CARLING D,et al.AMP-activated protein kinase:ancient energy gauge provides clues to modern understanding of metabolism[J].Cell Metabolism,2005,1(1):15-25.

[35] HARDY D.The role of the liver X receptor (LXR) in the fetal programming of hepatic gluconeogenesis[D].Ph.D.Thesis.Richmond Street,London,Ontario,Canada:The University of Western Ontario,2013.
[36] VO T X,REVESZ A,SOHI G,et al.Maternal protein restriction leads to enhanced hepatic gluconeogenic gene expression in adult male rat offspring due to impaired expression of the liver X receptor[J].Journal of Endocrinology,2013,218(1):85-97.

[37] 陈灰.脂联素激活AMPK信号通路调控奶牛肝细胞脂代谢的相关机制[D].硕士学位论文.长春:吉林大学,2013. CHEN H.Relevant mechanism of adiponection activating the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes[D].Master's Thesis.Changchun:Jilin University,2013.(in Chinese)
[38] STOECKMAN A K,TOWLE H C.The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression[J].Journal of Biological Chemistry,2002,277(30):27029-27035.

[39] CHO K,CHUNG J Y,CHO S K,et al.Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway[J].Scientific Reports,2015,5:8145.
[40] KIM Y W,KIM Y M,YANG Y M,et al.Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone,an AMPK-activating lignan in
Saururus chinensis[J].Free Radical Biology and Medicine,2010,48(4):567-578.

[41] LEE J,HONG S W,PARK S E,et al.AMP-activated protein kinase suppresses the expression of LXR/SREBP-1 signaling-induced ANGPTL8 in HepG2 cells[J].Molecular and Cellular Endocrinology,2015,414:148-155.
[42] HAN C Y,KI S H,KIM Y W,et al.Ajoene,a stable garlic by-product,inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation[J].Antioxidants & Redox Signaling,2011,14(2):187-202.

[43] YAP F,CRADDOCK L,YANG J.Mechanism of AMPK suppression of LXR-dependent
Srebp-1c transcription[J].International Journal Biological Science,2011,7(5):645-650.

[44] HIGUCHI N,KATO M,SHUNDO Y,et al.Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease[J].Hepatology Research,2008,38(11):1122-1129.

[45] YUAN H W,SHYY J Y J,MARTINS-GREEN M.Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1[J].Journal of Hepatology,2009,51(3):535-547.

[46] KOHJIMA M,HIGUCHI N,KATO M,et al.SREBP-1c,regulated by the insulin and AMPK signaling pathways,plays a role in nonalcoholic fatty liver disease[J].International Journal of Molecular Medicine,2008,21(4):507-511.
[47] DENTIN R,PÉGORIER J P,BENHAMED F,et al.Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression[J].The Journal of Biological Chemistry,2004,279(19):20314-20326.

[48] 张阔,杨静玉,吴春福.抑郁症的病理生理学基础及动物模型研究进展[J].神经药理学报,2017,7(4):8-16. ZHANG K,YANG J Y,WU C F.Progress on pathophysiology and animal models of depression[J].Acta Neuropharmacologica,2017,7(4):8-16.(in Chinese)
[49] NORIEGA L G,FEIGE J N,CANTO C,et al.CREB and ChREBP oppositely regulate
SIRT1 expression in response to energy availability[J].EMBO Reports,2011,12(10):1069-1076.

[50] XIA X,YAN J H,SHEN Y F,et al.Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis[J].PLoS One,2011,6(2):e16556.
[51] ILCOL Y O,CANSEV M,YILMAZ M S,et al.Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats:involvement of the sympathoadrenal system[J].Archives of Physiology and Biochemistry,2007,113(4/5):186-201.
[52] ILCOL Y O,CANSEV M,YILMAZ M S,et al.Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin:muscarinic and nicotinic acetylcholine receptors are both involved in their actions[J].Neuroscience Letters,2008,431(1):71-76.

[53] CANSEV M,ILCOL Y O,YILMAZ M S,et al.Choline,CDP-choline or phosphocholine increases plasma glucagon in rats:involvement of the peripheral autonomic nervous system[J].European Journal of Pharmacology,2008,589(1/2/3):315-322.
[54] HUNTINGTON G B,HARMON D L,RICHARDS C J.Sites,rates,and limits of starch digestion and glucose metabolism in growing cattle[J].Journal of Animal Science,2006,84(Suppl.13):E14-E24.
[55] ESPOSITO G,IRONS P C,WEBB E C,et al.Interactions between negative energy balance,metabolic diseases,uterine health and immune response in transition dairy cows[J].Animal Reproduction Science,2014,144(3/4):60-71.
[56] GAO B.Cytokines,STATs and liver disease[J].Cellular & Molecular Immunology,2005,2(2):92-100.
[57] SUN Q L,LIU Q Y,ZHENG Y Y,et al.Rapamycin suppresses TLR4-triggered IL-6 and PGE2 production of colon cancer cells by inhibiting
TLR4 expression and NF-κB activation[J].Molecular Immunology,2008,45(10):2929-2936.

[58] SHI S Y,LUK C T,SCHROER S A,et al.Janus kinase 2(JAK2) dissociates hepatosteatosis from hepatocellular carcinoma in mice[J].The Journal of Biological Chemistry,2017,292(9):3789-3799.

[59] 李士坤.多烯磷脂胆碱联合葛根素对非酒精性脂肪肝患者血清IL-6、IL-8、TNF-α水平的影响[J].社区医学杂志,2015,13(8):48-49. LI S K.Effect of polyene phospholipid choline combined with puerarin on serum IL-6,IL-8 and TNF-α levels in patients with non-alcoholic fatty liver[J].Journal of Community Medicine,2015,13(8):48-49.(in Chinese)
[60] KIYICI S,BASARAN N F,CAVUN S,et al.Central injection of CDP-choline suppresses serum ghrelin levels while increasing serum leptin levels in rats[J].European Journal of Pharmacology,2015,764:264-270.
[61] 李红山,朱德东,郑南红,等.姜黄素对实验性脂肪肝瘦素及其受体的干预作用[J].中国卫生检验杂志,2014,24(19):2737-2739. LI H S,ZHU D D,ZHENG N H,et al.Intervention effect of curcumin on leptin and its receptors in experimental fatty liver[J]. Chinese Journal of Health Laboratory Technology,2014,24(19):2737-2739.(in Chinese)
[62] INOUE H,OGAWA W,ASAKAWA A,et al.Role of hepatic STAT3 in brain-insulin action on hepatic glucose production[J].Cell Metabolism,2006,3(4):267-275.

[63] YOON J C,PUIGSERVER P,CHEN G X,et al.Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1[J].Nature,2001,413(6852):131-138.

[64] QU S,ALTOMONTE J,PERDOMO G,et al.Aberrant forkhead box O1 function is associated with impaired hepatic metabolism[J].Endocrinology,2006,147(12):5641-5652.

[65] 陈金成,张吟.AMPK与肝脏糖异生研究进展[J].中国现代应用药学,2017,34(7):1062-1067. CHEN J C,ZHANG Y.Research progress of AMPK and hepatic glucolipid metabolism[J].Chinese Journal of Modern Applied Pharmacy,2017,34(7):1062-1067.(in Chinese)
[66] 刘徽,朱波,林治华.IL-6信号通路与肿瘤[J].细胞与分子免疫学杂志,2011,27(3):353-355. LIU H,ZHU B,LIN Z H.IL-6 signaling pathway and tumor[J].Chinese Journal of Cellular and Molecular Immunology,2011,27(3):353-355.(in Chinese)
[67] LI W W,MA F F,ZHANG L Y,et al.S-propargyl-cysteine exerts a novel protective effect on methionine and choline deficient diet-induced fatty liver via Akt/Nrf2/HO-1 pathway[J].Oxidative Medicine and Cellular Longevity,2016,2016:4690857.
[68] GARCIA M C,AMANKWA-SAKYI M,FLYNN T J.Cellular glutathione in fatty liver
in vitro models[J].Toxicology
in Vitro,2011,25(7):1501-1506.

[69] NGUYEN T,YANG C S,PICKETT C B.The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress[J].Free Radical Biology and Medicine,2004,37(4):433-441.

[70] LEE J M,HANSON J M,CHU W A,et al.Phosphatidylinositol 3-kinase,not extracellular signal-regulated kinase,regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells[J].The Journal of Biological Chemistry,2001,276(23):20011-20016.

[71] SCAPAGNINI G,VASTO S,ABRAHAM N G,et al.Modulation of Nrf2/ARE pathway by food polyphenols:a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders[J].Molecular Neurobiology,2011,44(2):192-201.

[72] KASPAR J W,NITURE S K,JAISWAL A K.Nrf2:INrf2(Keap1) signaling in oxidative stress[J].Free Radical Biology and Medicine,2009,47(9):1304-1309.

[73] WU B J,CHEN K,BARTER P J,et al.Niacin inhibits vascular inflammation via the induction of heme oxygenase-1[J].Circulation,2012,125(1):150-158.

[74] GHATTAS M H,CHUANG L T,KAPPAS A,et al.Protective effect of HO-1 against oxidative stress in human hepatoma cell line (HepG2) is independent of telomerase enzyme activity[J].International Journal of Biochemistry & Cell Biology,2002,34(12):1619-1628.

[75] WU P,JIANG W D,LIU Y,et al.Effect of choline on antioxidant defenses and gene expressions of Nrf2 signaling molecule in the spleen and head kidney of juvenile Jian carp (
Cyprinus carpio var. Jian)[J].Fish & Shellfish Immunology,2014,38(2):374-382.

[76] WANG P,CONG M,LIU T H,et al.FoxA2 inhibits the proliferation of hepatic progenitor cells by reducing PI3K/Akt/HK2-mediated glycolysis[J].Journal of Cellular Physiology,2020,235(12):9524-9537.

[77] BUCHANAN F G,MCREYNOLDS M,COUVILLON A,et al.Requirement of phospholipase D1 activity in H-Ras
V12-induced transformation[J].Proceedings of the National Academy of Sciences of the United States of America,2005,102(5):1638-1642.

[78] YALCIN A,CLEM B,MAKONI S,et al.Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling[J].Oncogene,2010,29(1):139-149.

[79] CLEM B F,CLEM A L,YALCIN A,et al.A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling[J].Oncogene,2011,30(30):3370-3380.

[80] COLEMAN DA N,VAILATI-RIBONI M,ELOLIMY A A,et al.Hepatic betaine-homocysteine methyltransferase and methionine synthase activity and intermediates of the methionine cycle are altered by choline supply during negative energy balance in Holstein cows[J].Journal of Dairy Science,2019,102(9):8305-8318.

[81] DUCKER G S,RABINOWITZ J D.One-carbon metabolism in health and disease[J].Cell Metabolism,2017,25(1):27-42.

[82] ZHOU Y F,ZHOU Z,BATISTEL F,et al.Methionine and choline supply alter transmethylation,transsulfuration,and cytidine 5'-diphosphocholine pathways to different extents in isolated primary liver cells from dairy cows[J].Journal of Dairy Science,2018,101(12):11384-11395.

[83] SUGIMOTO H,BANCHIO C,VANCE D E.Transcriptional regulation of phosphatidylcholine biosynthesis[J].Progress in Lipid Research,2008,47(3):204-220.

[84] MELLOTT T,LOPEZ-COVIELLA I,BLUSZTAJN J K,et al.Mitogen-activated protein kinase kinase negatively modulates ciliary neurotrophic factor-activated choline acetyltransferase gene expression[J].European Journal of Biochemistry,2002,269(3):850-858.

[85] NIE Y Z,ERION D M,YUAN Z L,et al.STAT3 inhibition of gluconeogenesis is downregulated by SirT1[J].Nature Cell Biology,2009,11(4):492-500.